Demonstration of the interaction of native C1 with monomeric immunoglobulins and C1 inhibitorZICCARDI, R. J.The Journal of immunology (1950). 1985, Vol 134, Num 4, pp 2559-2563, issn 0022-1767Article

Regulation of the activation of C1 in serumFAULMANN, E. L; BOYLE, M. D. P.Molecular immunology. 1987, Vol 24, Num 6, pp 655-660, issn 0161-5890Article

A STUDY OF COMPLEMENT FUNCTIONS IN A FAMILY WITH HEREDITARY ANGIANEUROTIC EDEMA.CASALI P; RUGARLI C; ZANUSSI C et al.1975; BOLL. IST. SIEROTERAP. MILAN.; ITAL.; DA. 1975; VOL. 34; NO 5; PP. 405-408; ABS. ITAL.; BIBL. 18 REF.Article

Enxymatic inactivation of human plasma C1-inhibitor and α₁-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastaseCATANESE, J; KRESS, L. F.Biochimica et biophysica acta. 1984, Vol 789, Num 1, pp 37-43, issn 0006-3002Article

Plasma C1 inhibitor in malignant diseases : functional activity versus concentrationSTARCEVIC, D; JELIC-IVANOVIC, Z; KALIMANOVSKA, V et al.Annals of clinical biochemistry. 1991, Vol 28, pp 595-598, issn 0004-5632, 6Article

Studies on the dose dependence of endotoxin-induced in vitro activation of the complement systemROEISE, O; GARRED, P; MOLLNES, T. E et al.European surgical research. 1989, Vol 21, Num 1, pp 34-41, issn 0014-312XArticle

Characterization of recombinant C1 inhibitor P1 variantsELDERING, E; HUIJBREGTS, C. M; LUBBERS, T. P et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 10, pp 7013-7020, issn 0021-9258Article

Purification of C1 inhibitor: a new approach for the isolation of this biologically impostant plasma protease inhibitorPROGRAIS, L. J. JR; HAMMER, C. H; KATUSHA, K et al.Journal of immunological methods. 1987, Vol 99, Num 1, pp 113-122, issn 0022-1759Article

Déficit acquis en inhibiteur de la C1 estérase et syndrome lymphoprolifératif = Acquired C₁ esterase inhibitor deficiency in lymphoproliferative diseasesHORY, B; PANOUSE-PERRIN, J; DUPOND, J. L et al.La Revue de médecine interne (Paris). 1985, Vol 6, Num 3, pp 266-271, issn 0248-8663Article

A sensitive method to assay blood complement C1 inhibitor activityDROUET, C; ALIBEU, C; PONARD, D et al.Clinica chimica acta. 1988, Vol 174, Num 2, pp 121-130, issn 0009-8981Article

Cold promoted activation and factor XII, prekallikrein and C₁-inhibitorCZENDLIK, C; LAMMLE, B; DUCKERT, F et al.Thrombosis and haemostasis. 1985, Vol 53, Num 2, pp 242-244, issn 0340-6245Article

Hormonal regulation of complement biosynthesis in human cell lines. I: Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2FALUS, A; FEHER, K. G; WALCZ, E et al.Molecular immunology. 1990, Vol 27, Num 2, pp 191-195, issn 0161-5890Article

Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exonARIGA, T; IGARASHI, T; NARAYANASWAMY RAMESH et al.The Journal of clinical investigation. 1989, Vol 83, Num 6, pp 1888-1893, issn 0021-9738Article

Complement: function and clinical relevanceWILLIAMS, L. W; BURKS, A. W; STEELE, R. W et al.Annals of allergy. 1988, Vol 60, Num 4, pp 293-301, issn 0003-4738Article

Expression of functional human C1 inhibitor in COS cellsELDERING, E; NUIJENS, J. H; HACK, C. E et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 24, pp 11776-11779, issn 0021-9258Article

Genomic and cDNA cloning of the human C1 inhibitor: intron-exon junctions and comparison with other serpinsCARTER, P. E; DUNBAR, B; FOTHERGILL, J. E et al.European journal of biochemistry (Print). 1988, Vol 173, Num 1, pp 163-169, issn 0014-2956Article

C1-inhibitor attenuates human serum induced E-selectin expression of pig aortic endothelial cellsSØLVIK, U. Ø; HARALDSEN, G; FIANE, A. E et al.Transplantation proceedings. 2001, Vol 33, Num 1-2, pp 789-790, issn 0041-1345Conference Paper

Hormonal regulation of complement biosynthesis in human cell lines. II: Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell lineFALUS, A; ROKITA, H; WALCZ, E et al.Molecular immunology. 1990, Vol 27, Num 2, pp 197-201, issn 0161-5890Article

Functional and structural similarities between protease nexin I and C1 inhibitorVAN NOSTRAND, W. E; MCKAY, L. D; BAKER, J. B et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 8, pp 3979-3983, issn 0021-9258Article

Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sitesBRUCH, M; WEISS, V; ENGEL, J et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 32, pp 16626-16630, issn 0021-9258Article

Transcriptional regulation of the C1 inhibitor gene by γ-interferonKAMYAR ZAHEDI; PRADA, A. E; DACIS, A. E et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 13, pp 9669-9674, issn 0021-9258Article

Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor geneLEVY, N. J; RAMESH, N; CICARDI, M et al.Proceedings of the National Academy of Sciences of the United States of America. 1990, Vol 87, Num 1, pp 265-268, issn 0027-8424Article

Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subsomponent C1qKILCHHERR, E; SCHUMAKER, V. N; PHILLIPS, M. L et al.The Journal of immunology (1950). 1986, Vol 137, Num 1, pp 255-262, issn 0022-1767Article

Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1TENNER, A. J; FRANK, M. M.The Journal of immunology (1950). 1986, Vol 137, Num 2, pp 625-630, issn 0022-1767Article

Page / 2